Unique ID issued by UMIN | UMIN000043854 |
---|---|
Receipt number | R000050051 |
Scientific Title | A multicenter, open-label, single-blind, randomized, parallel-group study to evaluate the utility of indigocarmine and acetic acid-indigocarmine mixture (AIM) for the diagnosis of colonic serrated lesions in the right side colon |
Date of disclosure of the study information | 2021/04/14 |
Last modified on | 2021/04/06 16:15:42 |
The usefulness of AIM in colonoscopy
The usefulness of AIM in colonoscopy (cAIM study)
A multicenter, open-label, single-blind, randomized, parallel-group study to evaluate the utility of indigocarmine and acetic acid-indigocarmine mixture (AIM) for the diagnosis of colonic serrated lesions in the right side colon
A multicenter, open-label, single-blind, randomized, parallel-group study to evaluate the utility of indigocarmine and acetic acid-indigocarmine mixture (AIM) for the diagnosis of colonic serrated lesions in the right side colon (cAIM study)
Japan |
Serrated lesion
Gastroenterology |
Others
NO
The effect of AIM
Efficacy
Additional effect of AIM on detection of colonic serrated lesions including sessile serrated lesion(SSL)
Interventional
Parallel
Randomized
Individual
Single blind -participants are blinded
Placebo
3
Prevention
Medicine |
normal observation
observation with indigocarmine
observation with acetic acid-indigocarmine mixture(AIM)
20 | years-old | <= |
90 | years-old | > |
Male and Female
(1) Patients who are between 20 years and 90 years old at the time of obtaining consent
(2) A person for whom the patient's written consent has been obtained
(3) Patients who are scheduled for screening colonoscopy (e.g., fecal occult blood, cancer screening, and colonoscopy with no endoscopic treatment within 1 year)
(1) Familial colorectal adenomatosis, Lynch syndrome, serrated polyp syndrome(SPS)
(2) Patients with a history of colorectal cancer surgery
(3) Patients with endoscopic treatment of the colon within 1 year
(4) Ulcerative colitis and Crohn's disease
(5) Difficulty with endoscopic examination and treatment due to inability to temporarily stop taking antithrombotic or anticoagulant drugs
(6) Patents with an infectious disease that requires systemic treatment
(7) Pregnant and lactating women
(8) Patients with a history of hypersensitivity to indigocarmine or acetic acid
(9) Patients who are deemed unsuitable as research subjects by the principal investigator or sub-researcher
1311
1st name | Hideaki |
Middle name | |
Last name | Kinugasa |
Okayama University Hospital
Department of endoscopy
700-8558
2-5-1 Shikata-cho, Kita-ku, Okayama
0862357219
hkinugasa14@okayama-u.ac.jp
1st name | Hideaki |
Middle name | |
Last name | Kinugasa |
Okayama University Hospital
Department of endoscopy
700-8558
2-5-1 Shikata-cho, Kita-ku, Okayama
0862357219
hkinugasa14@okayama-u.ac.jp
Okayama University
Okayama University
Other
Okayama University Hospital
2-5-1 Shikata-cho, Kita-ku, Okayama
0862357219
hkinugasa14@okayama-u.ac.jp
NO
2021 | Year | 04 | Month | 14 | Day |
Unpublished
Preinitiation
2021 | Year | 02 | Month | 24 | Day |
2021 | Year | 02 | Month | 24 | Day |
2021 | Year | 04 | Month | 14 | Day |
2023 | Year | 12 | Month | 31 | Day |
2021 | Year | 04 | Month | 06 | Day |
2021 | Year | 04 | Month | 06 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050051
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |